Natural bactericidal resistance to Mycobacterium bovis BCG is under the control of a single gene, designated Bcg. Lung granuloma formation in susceptible (Bcge) and resistant (Bcgr) mice was studied in two sets of Bcg-congenic systems, namely, the BALB/c (Bcg$)-C.D2 (BALB/c.Bcg') pair and the B10.A (Bcgs)-BlO.Ar (Bcgj) pair, by using BCG as well as foreign body granuloma-inducing agents (dextran beads). Large granulomas of the lung induced by the intratracheal instillation of either BCG or dextran beads developed in Bcg' mice. In contrast, minimal inflammation was produced in Bcg( mice given BCG or dextran beads.
beads contained high levels of interleukin-1 (IL-1) activity but not interleukin-2 (IL-2) or interleukin-4 (IL-4) activity. Very low IL-1 activity was detected in extracts from Bcgf mice injected with BCG and dextran beads. The activity of IL-1 was correlated closely with the activity and size of the granulomatous inflammation in mice.
These results suggest that pleiotropic effects of the Bcg gene are involved in the development of granulomas induced by either BCG or nonspecific foreign body agents (dextran beads) and that monokines participate in granuloma formation.
Mice infected with Mycobacterium bovis BCG exhibit a spectrum of immunologic and/or inflammatory responses. The characteristic pathologic feature of the infection is granulomatous inflammation (1, 16) . In mice, early bactericidal resistance of BCG is controlled by the chromosome 1 Bcg gene, which exists in two allelic forms: Bcgr (resistant) and Bcgs (susceptible) (7, 10, 27) . The Bcg gene acts very early in the host response to infection and is phenotypically expressed as an intrinsic function of the macrophage (6, 20, 29) . The role of the Bcg gene in granuloma formation has not yet been clarified.
The aim of the present study was to determine whether the Bcg gene participates in granuloma formation induced by BCG as well as by foreign bodies. We show that the Bcg gene may regulate the development of granulomas induced by either BCG or nonspecific irritants (dextran beads) and that the activity and/or size of both lesions correlates with interleukin-1 (IL-1) activity.
MATERIALS AND METHODS
Mice. Two sets of congenic strains were used in this study as described previously (5, 6) . The first pair was a BALB/c (BALB/c.Bcgs)-C.D2 (BALB/c.Bcgr) combination. C.D2 congenic mice were bred from the breeding pairs of the C.D2-Idh-Ibb-Pep-3b line. These mice were originally de- rived by the NX backcross system that was aimed toward the transfer of the Idh-Ib allele (located on chromosome 1) from DBA/2 donors onto a BALB/c background. A second pair of congenic mice, the B10.A (B10.A.Bcgs)-B10.Ar (B1O.A.Bcgr) pair, was also used in this study. The congenic B10.Ar strain was constructed by the backcross NX system by using resistance to BCG as a selective agent. The resistant Bcgr allele was donated by strain A/J. Inbred B1O.A-B1O.A9) were negative (5, 6) . All mice were between 8 and 12 weeks of age at the time they were used.
Induction of pulmonary granulomatous inflammation. BCG lung granulomas were induced in mice by the intratracheal injection of a 0.1-ml suspension containing approximately 4 x 104 CFU of M. bovis BCG strain Tokyo as described previously (16) . BCG was kindly supplied by Tohru Tokunaga, Department of Tuberculosis, National Institute of Health, Tokyo. Dextran bead lung granulomas were induced in mice by the intratracheal injection of a 0.1-ml suspension of dextran beads (Sephadex G-50; Pharmacia Fine Chemicals, Piscataway, N.J.) at a concentration of 1.5 x 105 beads per ml as described previously (2, 14) .
Histologic examination. Histologic sections were made from each excised lung. These were prepared at a thickness of 5 ,im and were stained with hematoxylin and eosin (HE).
Determination of lung index. To determine the activity of the BCG-induced granulomatous inflammation, lung indexes were used. Previous reports have indicated that a considerable proportion of the increase in lung weight as a consequence of BCG injection is due to an increase in cellularity in the organ (1, 21) . The lung index was calculated as follows Measurement of the granuloma radii with dextran beads. By using a previously described method (2, 14) , dextran bead-induced granulomatous reactions were quantitated by GENETIC CONTROL OF GRANULOMATOUS RESPONSES IN MICE measuring the thickness as the expressed radius of cellular infiltration surrounding the injected beads, using an ocular micrometer and light microscope. A bead size 50 to 80 ,um in diameter was selected for measurement. At least 10 granulomas from different sections of each lung were measured, and the values were reported as the mean radius in micrometers + the standard error of the mean (SEM). We performed three to four independent experiments with three or four mice per condition. Thus, the mean + SEM was derived from the determinations of 120 to 160 granulomas. Under this condition, the SEM averaged less than 5 to 10%.
Aqueous lung extracts. Aqueous extracts of granulomatous lungs were prepared by the method described previously (2, 14, 16) . Briefly, lungs were inflated with 1 ml of physiologic saline and were homogenized in 5 ml of saline by using a Polytron (Brinkmann Instruments, Westbury, N.Y.) for30 s. Tissue was kept on ice during these procedures. Homogenized tissues were then centrifuged in a refrigerated unit at 2,000 x g for 30 min, and the tissue pellet was discarded. Samples were then sterilized with a membrane (pore size, 0.45 jim; Millipore Corp., Bedford, Mass.) and were stored at -70°C until use. Aqueous granuloma extracts contained 0.4 to 0.5 mg of protein per ml of saline (2, 14, 16) .
Determination of lung CFU. Growth of BCG in the lung was monitored against time by plating 10-fold serial dilutions of whole-lung homogenates on Middlebrook 7H10 agar (Difco Laboratories, Detroit, Mich.). Bacterial colonies were counted after incubation at 37°C for 16 days (10, 20) .
Assays for cytokine activities. The thymocyte proliferation activity of IL-1 was determined by its capacity to stimulate C3H/HeJ mouse thymocytes in the presence of phytohemagglutinin-P (Difco) as described previously (19) . IL-2 and IL-4 activities were assayed by their ability to stimulate proliferation of CTLL cells (8, 9, 25 (8) . Units were expressed as the mean ± SEM in triplicate. As positive controls in cytokine assays, we used recombinant human IL-lp (specific activity, 2 x 107 U/mg; Otsuka Pharmaceutical Co., Tokushima, Japan), recombinant human IL-2 (specific activity, 1 x 107 U/mg; Shionogi Pharmaceutical Co., Osaka, Japan), and recombinant murine IL-4 (specific activity, 1 x 108 U/mg; Genzyme, Boston, Mass.). Statistical analyses. The Mann-Whitney U test for the analysis of nonparametric data was used; P values of less than 0.05 were considered significant. All statistical analyses were performed by using Statview 512+ (Brainpower, Calabasas, Calif.) run on a Macintosh II PC (Apple, Cupertino, Calif.).
RESULTS
Induction of pulmonary granulomatous inflammation by BCG. In BALB/c (Bcgs) mice, histology of the lung showed severe, diffuse, intraalveolar and interstitial inflammatory cell infiltration at an early stage (1 to 3 days) after intratracheal viable BCG challenge. The infiltrate was primarily composed of large macrophages, mature lymphocytes, and scattered neutrophils (Fig. 1A) . Two and three weeks after intratracheal BCG challenge, randomly distributed, wellorganized granulomas composed of epithelioid macrophages and lymphocytes were observed (Fig. 1B) . In contrast, C.D2 mice (BALB/c Bcg) showed only a very mild interstitial mononuclear cell infiltration at an early stage ( Fig. 1C ) and then showed insignificant lesions at the later times (Fig. 1D ). Similar results were found for the BlO.A-BlO.A' pair. In B1O.A (Bcgs) mice, diffuse infiltration of mononuclear cells was seen at an early stage (1 to 3 days) after the challenge (Fig. 1E) , and well-organized granulomas were found at later times (Fig. 1F) . Conversely, B1O.Ar Bcg' mice showed negligible lesions at both early and later stages ( Fig. 1G and  H) . The lung indexes were consistent with the results of morphologic features (Fig. 2) (10, 21, 26) . Foreign body granulomas of the lung induced by nonspecific irritants (dextran beads). To test the possibility that the Bcg gene is involved in the development of foreign body granuloma formation, mice were injected intratracheally with dextran beads. It has been reported that dextran beadinduced granulomas in mice are foreign body-type lesions and the lesions reached maximum size by 3 days (2, 14) . Large granulomas induced by dextran beads were found in mice bearing the Bcgs gene, such as BALB/c (Fig. 4A ) and B1O.A (Fig. 4C) mice. The lesions were composed predominantly of macrophages. The granulomas were conspicuous by day 1, reached maximum size (50-to 60-jim radius) by day 3, and then gradually decreased in size thereafter. In contrast, inflammatory reactions caused by dextran beads in mice bearing the Bcg' gene, such as C.D2 (Fig. 4B ) and B1O.Ar (Fig. 4D ) mice, were considerably smaller and were composed of macrophages. A summary of dextran beadinduced granulomas in various strains of mice is shown in Fig. 5 .
Cytokine activities in granulomatous lesions. We have proposed the concept that monokines play a crucial role in the induction of experimental granulomas at an early stage on the basis of the results that maximum monokine (IL-1) activity in the lesions was observed 3 days after the intratracheal challenge of granuloma-inducing agents, including artificial microparticles and BCG (14, 16, 17) . To confirm this, we examined cytokine activities in the lung extracts. Significant IL-1-like activities were observed in the extracts prepared from Bcgs (high granuloma producers [BALB/c and BlO.A]) mice bearing pulmonary granulomatous inflammation induced by BCG (Fig. 6) . By contrast, IL-1-like activity (Fig. 7) . For Bcgr mice injected intratracheally with dextran beads, their lung extracts contained a lower amount of IL-1-like activities. BCG or dextran beads themselves seemed to have no direct effect on this assay, since extracts prepared from mice injected with BCG or dextran beads immediately before sacrifice showed no IL-1 activity. The thymocyte proliferation assay reflects several cytokine activities (IL-1, IL-2, and IL-4) in the samples (18, 25, 28) , and CTLL cells could respond to IL-2 (28) and IL-4 (9, 25). We therefore examined IL-2 and IL-4 activities by using the CTLL proliferation assay to clarify the nature of the thymocyte-proliferative response in the standard IL-1 assay described above. No CTLL proliferation activity was detected in the lung extracts of granuloma-bearing mice that had thymocyte-proliferative activity. Thus, neither IL-2 nor IL-4 activity was detected in the extracts. Our failure to detect both IL-2 and IL-4 could be due either to a relative inability of granuloma cells to produce these lymphokines or to the presence of inhibitory factors that interfere with the expression of IL-2 and/or IL-4 activity. We therefore examined the abilities of the extracts to neutralize or inhibit the proliferative activity of recombinant IL-2 and IL-4. No significant neutralizing activity against IL-2 and IL-4 was detected in the supernatants (data not shown). The results suggest that the activity was in fact due to IL-1. The results are consistent with our previous reports that T-cell-derived lymphokines, such as IL-2 and IL-4, were not found in the lung extracts from mice bearing hypersensitivity or foreign body granulomas (14, 16, 17) .
DISCUSSION
The data reported in this paper suggest that the Bcg gene regulates granuloma formation induced by either BCG or nonspecific stimuli (dextran beads) and that the development of lesions is clearly correlated with the local production and/or release of monokines, such as IL-1. The results are consistent with our previous reports that macrophages and monokines play a critical role in the development of murine pulmonary granuloma formation in vivo and in vitro (13, 14, 16, 17, 24) .
Granuloma formation is the result of a series of complex inflammatory events. In recent years, evidence has accumulated that genetic factors (1, 16, 21) , macrophages, and cytokines, especially monokines such as IL-1 and tumor necrosis factor-ct (TNF-a), play an important role in the initiation and maintenance of granuloma formation in mice (4, (13) (14) (15) (16) (17) 24) and human granulomatous diseases, including tuberculosis and sarcoidosis (3, 11, 23) . In the case of BCG-induced granulomas in mice, it has been found that innate resistance of inbred mice to infection with BCG is regulated by a single, dominant, autosomal gene designated Bcg (7, 10, 27) . The genetically resistant host is able to control the net bacterial growth without raising a significant immunologic and/or inflammatory response. The present study showed that Bcgs mice (BALB/c and B1O.A) were high granuloma producers and that Bcgr mice (C.D2 and B1O.Ar) were low granuloma producers. A significant amount of IL-1 activity was found in the extracts of granulomatous lungs from Bcg' mice (high granuloma producers), while a very small amount of the activity was detected in Bcgr mice (low granuloma producers). These results clearly suggest that the product(s) of the gene regulating granuloma formation is expressed in the process, generating factors such as IL-1 from activated macrophages and influencing an early phase of the host defense mechanism against BCG infection. Thus, these mediators may be closely related to granuloma formation. Also, these findings support the concept that mice genetically resistant (Bcg') to BCG infection are able to prevent bacterial growth and/or invasion without the need for inflammatory responses such as granulomas, whereas genetically susceptible mice (Bcgs) will eventually control bacterial load with the acquisition of inflammatory responses (26, 27, 29) . Therefore, insufficient release and/or production of IL-1 in the Bcgr mice may be responsible for the low macrophage response to BCG and for the unremarkable granuloma formation observed.
It has been reported that dextran bead-induced granulomas in mice are foreign body-type lesions (2, 4, 14, 24) and that macrophages and monokines play a critical role in murine granulomas induced by artificial microparticles both in vivo and in vitro (4, 13, 14, 24) . The results that Bcgs mice were high granuloma producers and Bcgr mice were low granuloma producers in response to BCG as well as to nonspecific stimuli (dextran beads) suggest that the Bcg gene regulates responses to both BCG and nonspecific granulomainducing agents such as dextran beads. Because the gene is expressed as an intrinsic function of macrophages (5, 6, 20, 29) , which play a critical role in granuloma formation, it is reasonable to assume that the gene may have influence not only on BCG but also on foreign body granuloma formation. In fact, it has been reported that the Bcg gene controlled nonspecific bactericidal activities to BCG, Salmonella typhimurium, Brucella abortus, and Escherichia coli (5, 6). These The link between IL-1 and IL-2 is an essential element in immune processes (18, 28) . However, little is known about the role and interaction of IL-1 and IL-2 in vivo. The present results of IL-1 activities in the granulomatous lesions of high responder mice suggest that the activation of macrophages plays an important role in granuloma formation. In contrast, T-cell-derived lymphokines, including IL-2 and IL-4, were not detectable in the extracts. These results are in agreement with our previous reports of the dissociation between IL-1 and T-cell-derived lymphokine activities in hypersensitivity, BCG, and foreign body granulomas in mice (14, 16, 17, 24) and the fact that no IL-2 activity was found in the bronchoalveolar lavage fluid from patients with active pulmonary sarcoidosis (22) , although it was detectable in culture supernatants of lung T cells from these patients (12, 22) . Macrophages are the predominant cells in both BCG and foreign body-type granulomatous lesions. Therefore, the lesions could evolve in the absence of T-cell-derived lymphokines such as IL-2 and IL-4. In addition, foreign body-type lung granulomas were inducible in both normal mice and athymic nude mice (2) . These results suggest that T lymphokines play little role in granuloma formation. However, certain T lymphokines, including the migration inhibition factor and the macrophage chemotactic factor, as well as monokines, play important roles in granuloma formation, especially in hypersensitive-type lesions (16, 17) . Our data reported here cannot exclude the participation of T cells and T lymphokines in granuloma formation. Further study is necessary to confirm this possibility.
The results described in this paper provide novel evidence that the Bcg gene regulates both BCG and foreign body-type granuloma formation in mice. In addition, IL-1 activity is associated with the development of lesions. Thus, such processes are under genetic control. 
